Lv41
660 积分 2024-06-11 加入
A predictive model for immunotherapy efficacy in non-small cell lung cancer constructed based on CT image-weighted radiomics score
1小时前
已完结
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer
3个月前
已完结
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
4个月前
已完结
An immunomechanical checkpoint PYK2 governs monocyte-to-macrophage differentiation in pancreatic cancer
4个月前
已完结
IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC
4个月前
已关闭
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
5个月前
已完结
How the bone microenvironment shapes the pre-metastatic niche and metastasis
5个月前
已完结
Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance
5个月前
已完结
Targeting Tumor Physical Microenvironment for Improved Radiotherapy
6个月前
已完结
Metabolic landscape of disseminated cancer dormancy
6个月前
已完结
皖公网安备34019202002308
